News

Danish pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping ...
Novo Nordisk CEO Lars Fruergaard Jorgensen is stepping down per mutual agreement with the company. The company said Friday he ...
Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.
Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has ...
Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...
Most major stock indexes across the globe moved upwards on a weekly basis, taking support from the uptick in US equities.
Discussions between Novo Nordisk and the Novo Nordisk Foundation that controls the company regarding a CEO change have been ...